COPN — Cosmo Pharmaceuticals NV Cashflow Statement
0.000.00%
Last trade - 00:00- CH₣1.11bn
- CH₣1.07bn
- €96.72m
- 73
- 11
- 97
- 66
Annual cashflow statement for Cosmo Pharmaceuticals NV, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -21.3 | -6.93 | 24 | 24.5 | 7.61 |
| Depreciation | |||||
| Non-Cash Items | 6.98 | 16.1 | -11.1 | 10.2 | 14.8 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -10.3 | -2.27 | -7.7 | -15.3 | -3.03 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -18.8 | 13 | 12.6 | 33.2 | 33.6 |
| Capital Expenditures | -17.3 | -8.09 | -8.5 | -7.31 | -15.3 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -31.4 | 83.5 | 33.4 | 9 | 55.6 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -48.7 | 75.4 | 24.9 | 1.69 | 40.3 |
| Financing Cash Flow Items | -7.38 | -4.38 | -4.88 | -4.38 | -4.38 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -34.5 | -11.9 | -27.2 | -46.1 | -209 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -100 | 75.5 | 12.6 | -12.7 | -136 |